US Stock MarketDetailed Quotes

IGMS IGM Biosciences

Watchlist
  • 8.490
  • -0.760-8.22%
Trading Dec 12 14:38 ET
504.85MMarket Cap-2.35P/E (TTM)

IGM Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
4.33%-38.39M
29.62%-37.37M
16.82%-42.42M
-3,184.32%-192.23M
-26.81%-48.01M
0.72%-40.12M
-147.71%-53.11M
-31.13%-51M
95.32%-5.85M
-7.25%-37.86M
Net income from continuing operations
0.90%-61.43M
25.64%-47.9M
16.01%-49.82M
-11.45%-246.42M
-15.44%-60.7M
-6.81%-61.99M
-9.95%-64.42M
-14.29%-59.31M
-33.87%-221.1M
-3.82%-52.58M
Depreciation and amortization
2.12%2.31M
4.74%2.28M
30.77%2.18M
36.25%8.28M
14.91%2.18M
49.70%2.26M
50.48%2.17M
35.95%1.66M
35.48%6.08M
45.66%1.9M
Other non cash items
-52.05%2.52M
-14.60%2.56M
-15.85%2.55M
26.54%15.19M
-27.37%3.9M
81.83%5.26M
8.73%3M
208.66%3.03M
335.98%12.01M
739.22%5.37M
Change In working capital
-24.04%3.6M
84.69%-896K
39.60%-2.98M
-104.31%-6.69M
61.57%-643K
42.69%4.74M
-103.79%-5.85M
-471.76%-4.94M
2,306.86%155.17M
-135.50%-1.67M
-Change in prepaid assets
-129.50%-1.1M
85.30%-529K
1,801.72%987K
376.60%1.71M
509.75%1.64M
274.82%3.73M
-283.72%-3.6M
-106.22%-58K
110.89%359K
75.08%-400K
-Change in payables and accrued expense
213.06%5.2M
273.53%2.27M
-13.87%-3.98M
-139.30%-4.21M
-567.92%-1.06M
-79.12%1.66M
-134.50%-1.31M
-296.60%-3.5M
-19.05%10.7M
-102.20%-159K
-Change in other current assets
114.71%292K
357.89%174K
232.47%204K
120.06%194K
45.00%174K
112.11%136K
442.86%38K
-631.03%-154K
-98.16%-967K
195.24%120K
-Change in other current liabilities
0.36%-273K
-189.57%-1.56M
143.08%305K
41.34%-2.26M
13.81%-743K
73.78%-274K
46.57%-537K
25.00%-708K
-29.05%-3.86M
-10.51%-862K
-Change in other working capital
-1.38%-516K
-179.91%-1.25M
4.79%-497K
-101.43%-2.13M
-75.00%-651K
-53.78%-509K
---448K
---522K
--148.93M
---372K
Cash from discontinued investing activities
Operating cash flow
4.33%-38.39M
29.62%-37.37M
16.82%-42.42M
-3,184.32%-192.23M
-26.81%-48.01M
0.72%-40.12M
-147.71%-53.11M
-31.13%-51M
95.32%-5.85M
-7.25%-37.86M
Investing cash flow
Cash flow from continuing investing activities
-33.57%12.99M
487.73%24.52M
-87.61%8.65M
130.29%68.36M
21.89%-14.69M
621.58%19.55M
96.56%-6.33M
465.51%69.82M
-1,559.44%-225.64M
-939.78%-18.81M
Net PPE purchase and sale
58.32%-1.29M
69.79%-1.18M
36.91%-2.48M
-21.31%-12.38M
46.27%-1.45M
-13.72%-3.08M
-114.65%-3.91M
-32.25%-3.94M
22.94%-10.21M
-52.86%-2.7M
Net investment purchase and sale
-36.94%14.27M
1,165.75%25.71M
-84.90%11.14M
137.48%80.74M
17.81%-13.25M
2,282.45%22.63M
98.68%-2.41M
557.40%73.76M
-850.52%-215.44M
-502.60%-16.12M
Cash from discontinued investing activities
Investing cash flow
-33.57%12.99M
487.73%24.52M
-87.61%8.65M
130.29%68.36M
21.89%-14.69M
621.58%19.55M
96.56%-6.33M
465.51%69.82M
-1,559.44%-225.64M
-939.78%-18.81M
Financing cash flow
Cash flow from continuing financing activities
-97.31%1.2M
-99.12%615K
102.67%152K
-47.55%115.07M
-16.60%402K
14,929.97%44.64M
-67.99%69.95M
4.17%75K
8,760.34%219.38M
-67.67%482K
Net common stock issuance
--0
----
----
-47.90%113.56M
--0
--44.62M
----
----
--217.99M
--0
Proceeds from stock option exercised by employees
5,359.09%1.2M
-35.52%648K
154.67%191K
7.81%1.5M
-16.60%402K
-92.59%22K
108.07%1.01M
-43.61%75K
-65.39%1.4M
-70.39%482K
Net other financing activities
--0
---33K
---39K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-97.31%1.2M
-99.12%615K
102.67%152K
-47.55%115.07M
-16.60%402K
14,929.97%44.64M
-67.99%69.95M
4.17%75K
8,760.34%219.38M
-67.67%482K
Net cash flow
Beginning cash position
-55.56%67.26M
-43.55%79.5M
-7.22%113.11M
-9.04%121.92M
-1.51%175.41M
-31.82%151.34M
85.01%140.82M
-9.04%121.92M
-44.40%134.04M
7.55%178.11M
Current changes in cash
-200.54%-24.2M
-216.28%-12.24M
-277.83%-33.61M
27.30%-8.81M
-10.88%-62.3M
154.87%24.07M
-92.79%10.52M
132.63%18.9M
88.68%-12.12M
-77.98%-56.19M
End cash Position
-75.45%43.07M
-55.56%67.26M
-43.55%79.5M
-7.22%113.11M
-7.22%113.11M
-1.51%175.41M
-31.82%151.34M
85.01%140.82M
-9.04%121.92M
-9.04%121.92M
Free cash flow
8.16%-39.68M
32.32%-38.59M
18.26%-44.9M
-1,174.13%-204.61M
-21.95%-49.46M
-0.19%-43.2M
-152.08%-57.02M
-31.21%-54.93M
88.38%-16.06M
-9.42%-40.55M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 4.33%-38.39M29.62%-37.37M16.82%-42.42M-3,184.32%-192.23M-26.81%-48.01M0.72%-40.12M-147.71%-53.11M-31.13%-51M95.32%-5.85M-7.25%-37.86M
Net income from continuing operations 0.90%-61.43M25.64%-47.9M16.01%-49.82M-11.45%-246.42M-15.44%-60.7M-6.81%-61.99M-9.95%-64.42M-14.29%-59.31M-33.87%-221.1M-3.82%-52.58M
Depreciation and amortization 2.12%2.31M4.74%2.28M30.77%2.18M36.25%8.28M14.91%2.18M49.70%2.26M50.48%2.17M35.95%1.66M35.48%6.08M45.66%1.9M
Other non cash items -52.05%2.52M-14.60%2.56M-15.85%2.55M26.54%15.19M-27.37%3.9M81.83%5.26M8.73%3M208.66%3.03M335.98%12.01M739.22%5.37M
Change In working capital -24.04%3.6M84.69%-896K39.60%-2.98M-104.31%-6.69M61.57%-643K42.69%4.74M-103.79%-5.85M-471.76%-4.94M2,306.86%155.17M-135.50%-1.67M
-Change in prepaid assets -129.50%-1.1M85.30%-529K1,801.72%987K376.60%1.71M509.75%1.64M274.82%3.73M-283.72%-3.6M-106.22%-58K110.89%359K75.08%-400K
-Change in payables and accrued expense 213.06%5.2M273.53%2.27M-13.87%-3.98M-139.30%-4.21M-567.92%-1.06M-79.12%1.66M-134.50%-1.31M-296.60%-3.5M-19.05%10.7M-102.20%-159K
-Change in other current assets 114.71%292K357.89%174K232.47%204K120.06%194K45.00%174K112.11%136K442.86%38K-631.03%-154K-98.16%-967K195.24%120K
-Change in other current liabilities 0.36%-273K-189.57%-1.56M143.08%305K41.34%-2.26M13.81%-743K73.78%-274K46.57%-537K25.00%-708K-29.05%-3.86M-10.51%-862K
-Change in other working capital -1.38%-516K-179.91%-1.25M4.79%-497K-101.43%-2.13M-75.00%-651K-53.78%-509K---448K---522K--148.93M---372K
Cash from discontinued investing activities
Operating cash flow 4.33%-38.39M29.62%-37.37M16.82%-42.42M-3,184.32%-192.23M-26.81%-48.01M0.72%-40.12M-147.71%-53.11M-31.13%-51M95.32%-5.85M-7.25%-37.86M
Investing cash flow
Cash flow from continuing investing activities -33.57%12.99M487.73%24.52M-87.61%8.65M130.29%68.36M21.89%-14.69M621.58%19.55M96.56%-6.33M465.51%69.82M-1,559.44%-225.64M-939.78%-18.81M
Net PPE purchase and sale 58.32%-1.29M69.79%-1.18M36.91%-2.48M-21.31%-12.38M46.27%-1.45M-13.72%-3.08M-114.65%-3.91M-32.25%-3.94M22.94%-10.21M-52.86%-2.7M
Net investment purchase and sale -36.94%14.27M1,165.75%25.71M-84.90%11.14M137.48%80.74M17.81%-13.25M2,282.45%22.63M98.68%-2.41M557.40%73.76M-850.52%-215.44M-502.60%-16.12M
Cash from discontinued investing activities
Investing cash flow -33.57%12.99M487.73%24.52M-87.61%8.65M130.29%68.36M21.89%-14.69M621.58%19.55M96.56%-6.33M465.51%69.82M-1,559.44%-225.64M-939.78%-18.81M
Financing cash flow
Cash flow from continuing financing activities -97.31%1.2M-99.12%615K102.67%152K-47.55%115.07M-16.60%402K14,929.97%44.64M-67.99%69.95M4.17%75K8,760.34%219.38M-67.67%482K
Net common stock issuance --0---------47.90%113.56M--0--44.62M----------217.99M--0
Proceeds from stock option exercised by employees 5,359.09%1.2M-35.52%648K154.67%191K7.81%1.5M-16.60%402K-92.59%22K108.07%1.01M-43.61%75K-65.39%1.4M-70.39%482K
Net other financing activities --0---33K---39K----------------------------
Cash from discontinued financing activities
Financing cash flow -97.31%1.2M-99.12%615K102.67%152K-47.55%115.07M-16.60%402K14,929.97%44.64M-67.99%69.95M4.17%75K8,760.34%219.38M-67.67%482K
Net cash flow
Beginning cash position -55.56%67.26M-43.55%79.5M-7.22%113.11M-9.04%121.92M-1.51%175.41M-31.82%151.34M85.01%140.82M-9.04%121.92M-44.40%134.04M7.55%178.11M
Current changes in cash -200.54%-24.2M-216.28%-12.24M-277.83%-33.61M27.30%-8.81M-10.88%-62.3M154.87%24.07M-92.79%10.52M132.63%18.9M88.68%-12.12M-77.98%-56.19M
End cash Position -75.45%43.07M-55.56%67.26M-43.55%79.5M-7.22%113.11M-7.22%113.11M-1.51%175.41M-31.82%151.34M85.01%140.82M-9.04%121.92M-9.04%121.92M
Free cash flow 8.16%-39.68M32.32%-38.59M18.26%-44.9M-1,174.13%-204.61M-21.95%-49.46M-0.19%-43.2M-152.08%-57.02M-31.21%-54.93M88.38%-16.06M-9.42%-40.55M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Salesforce
CRM
+0.98%
Microsoft
MSFT
+0.80%
Cisco
CSCO
+0.70%
Apple
AAPL
+0.68%
Advanced Micro Devices
AMD
+0.69%

Unlock the Full List